EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The predictive value of aGAPSS score combined with clinical factors for thrombosis in systemic lupus erythematosus

Juan Shi, Libo Ouyang, Qiong Ma, Peiming Zheng

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1909515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Juan Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Henan Provincial People's Hospital, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Thrombosis, Antibodies, Antiphospholipid, Antiphospholipid Syndrome. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study evaluated the predictive value of antiphospholipid antibodies (aPLs) combined with the adjusted global antiphospholipid syndrome score (aGAPSS) for thrombosis in hospitalized systemic lupus erythematosus (SLE) patients.

Methods

A retrospective analysis included 309 SLE patients (65 with in-hospital thrombosis, 244 without). Demographic, clinical, and serological data were collected. Least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression identified independent risk factors. A combined predictive model was constructed and internally validated using bootstrap.

Results

Patients with thrombosis were older, had higher smoking prevalence, LA ratio, and aGAPSS (all P < 0.05). Disease activity was significantly higher in the thrombosis group, as reflected by a higher mean SLEDAI score (14.29 ± 2.88 vs. 12.45 ± 1.62, P < 0.001). Multivariate analysis identified age (OR = 1.053), smoking (OR = 2.945), SLEDAI (OR = 1.312), LA ratio (OR = 17.432), and aGAPSS (OR = 1.514) as independent predictors. The combined model (aGAPSS + clinical covariates) achieved an area under the curve (AUC) of 0.832, significantly outperforming aGAPSS alone (AUC = 0.693; ΔAUC = 0.139, P < 0.001), with NRI of 0.356 and IDI of 0.142.

Conclusion

Integrating aGAPSS with clinical factors provides good discriminative ability for in-hospital thrombosis risk stratification in hospitalized SLE patients, offering a practical tool that may inform surveillance intensity and prophylactic consideration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicThrombosisAntibodies, AntiphospholipidAntiphospholipid SyndromeHumansFemaleRetrospective StudiesRisk FactorsAdultMaleMiddle AgedPredictive Value of TestsSeverity of Illness Index

Stichwörter der Autor:innen

antiphospholipid antibodiesantiphospholipid syndrome scorerisk predictionsystemic lupus erythematosusthrombosis

Substanzen

Antibodies, Antiphospholipid

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
  • Department of Blood Transfusion, Zhumadian Central Hospital, Zhumadian, Henan, China.

Zitieren

APA

Shi, J., Ouyang, L., Ma, Q., & Zheng, P. (2026). The predictive value of aGAPSS score combined with clinical factors for thrombosis in systemic lupus erythematosus. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1909515

Vancouver

Shi J, Ouyang L, Ma Q, Zheng P. The predictive value of aGAPSS score combined with clinical factors for thrombosis in systemic lupus erythematosus. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1909515

BibTeX
@article{Shi2026,
  author = {Shi, Juan and Ouyang, Libo and Ma, Qiong and Zheng, Peiming},
  title = {The predictive value of aGAPSS score combined with clinical factors for thrombosis in systemic lupus erythematosus},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1909515}
}
Kostenlos starten →